Stallion India Fluorochemicals Limited — Investor Meet, 06-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Stallion India Fluorochemicals reported strong Q3 & 9M FY26 results: 9M revenue up 41.7% to INR 321.18 Cr, PAT soared 72.8% to INR 32.9 Cr. Confident of FY26 guidance.

Key strategic moves: 10,000 MT R-32 plant in Bhilwara secured clearance (Aug 2026 commissioning), Mambattu blending facility expanding (March/April operational), and new helium ventures strengthen supply. Project delays are due to upgrades and capacity scale-ups for long-term growth. Management targets 30-35% CAGR over three years, driven by integration and higher-margin products. A INR 364 Cr rights issue will fund expansion while keeping the company debt-free.